INMED PHARMACEUTICALS (Germany) Price Prediction
| MWG0 Stock | 3.94 0.20 4.83% |
Oversold Vs Overbought
59
Oversold | Overbought |
Using INMED PHARMACEUTICALS hype-based prediction, you can estimate the value of INMED PHARMACEUTICALS INC from the perspective of INMED PHARMACEUTICALS response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in INMED PHARMACEUTICALS to buy its stock at a price that has no basis in reality. In that case, they are not buying INMED because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
INMED PHARMACEUTICALS after-hype prediction price | EUR 4.14 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
INMED |
INMED PHARMACEUTICALS Estimiated After-Hype Price Prediction Volatility
As far as predicting the price of INMED PHARMACEUTICALS at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in INMED PHARMACEUTICALS or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of INMED PHARMACEUTICALS, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
INMED PHARMACEUTICALS Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as INMED PHARMACEUTICALS is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading INMED PHARMACEUTICALS backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with INMED PHARMACEUTICALS, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.57 | 10.03 | 0.00 | 0.00 | 0 Events / Month | 0 Events / Month | Uncertain |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
3.94 | 4.14 | 0.00 |
|
INMED PHARMACEUTICALS Hype Timeline
INMED PHARMACEUTICALS INC is now traded for 3.94on Frankfurt Exchange of Germany. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. INMED is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is now at 0.57%. %. The volatility of related hype on INMED PHARMACEUTICALS is about 0.0%, with the expected price after the next announcement by competition of 3.94. The company had not issued any dividends in recent years. INMED PHARMACEUTICALS INC had 20:1 split on the 25th of September 2024. Assuming the 90 days trading horizon the next forecasted press release will be uncertain. Check out INMED PHARMACEUTICALS Basic Forecasting Models to cross-verify your projections. For more detail on how to invest in INMED Stock please use our How to Invest in INMED PHARMACEUTICALS guide.INMED PHARMACEUTICALS Related Hype Analysis
Having access to credible news sources related to INMED PHARMACEUTICALS's direct competition is more important than ever and may enhance your ability to predict INMED PHARMACEUTICALS's future price movements. Getting to know how INMED PHARMACEUTICALS's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how INMED PHARMACEUTICALS may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| APC | Apple Inc | 0.00 | 0 per month | 0.89 | 0.21 | 1.81 | (1.75) | 4.97 | |
| APC | Apple Inc | 0.00 | 0 per month | 0.98 | 0.21 | 1.88 | (1.73) | 5.24 | |
| APC | Apple Inc | 0.00 | 0 per month | 0.84 | 0.21 | 2.06 | (1.76) | 4.50 | |
| APC | Apple Inc | 0.00 | 0 per month | 1.04 | 0.19 | 2.22 | (1.83) | 6.45 | |
| APC | Apple Inc | 0.00 | 0 per month | 0.74 | 0.20 | 2.83 | (1.69) | 5.24 | |
| APC | Apple Inc | 0.00 | 0 per month | 1.00 | 0.22 | 1.88 | (1.61) | 6.46 | |
| MSF | Microsoft | 0.00 | 0 per month | 1.25 | 0.06 | 2.55 | (1.46) | 8.71 | |
| MSF | Microsoft | 0.00 | 0 per month | 1.38 | 0.05 | 2.35 | (1.75) | 9.11 | |
| MSF | Microsoft | 0.00 | 0 per month | 1.48 | 0.05 | 2.42 | (1.66) | 11.42 | |
| MSF | Microsoft | 0.00 | 0 per month | 1.33 | 0.05 | 2.04 | (1.49) | 8.79 |
INMED PHARMACEUTICALS Additional Predictive Modules
Most predictive techniques to examine INMED price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for INMED using various technical indicators. When you analyze INMED charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About INMED PHARMACEUTICALS Predictive Indicators
The successful prediction of INMED PHARMACEUTICALS stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as INMED PHARMACEUTICALS INC, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of INMED PHARMACEUTICALS based on analysis of INMED PHARMACEUTICALS hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to INMED PHARMACEUTICALS's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to INMED PHARMACEUTICALS's related companies.
Story Coverage note for INMED PHARMACEUTICALS
The number of cover stories for INMED PHARMACEUTICALS depends on current market conditions and INMED PHARMACEUTICALS's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that INMED PHARMACEUTICALS is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about INMED PHARMACEUTICALS's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Complementary Tools for INMED Stock analysis
When running INMED PHARMACEUTICALS's price analysis, check to measure INMED PHARMACEUTICALS's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy INMED PHARMACEUTICALS is operating at the current time. Most of INMED PHARMACEUTICALS's value examination focuses on studying past and present price action to predict the probability of INMED PHARMACEUTICALS's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move INMED PHARMACEUTICALS's price. Additionally, you may evaluate how the addition of INMED PHARMACEUTICALS to your portfolios can decrease your overall portfolio volatility.
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |